On the same evening earlier this month that Canopy Growth (TSX: CGC) (OTC: TWMJF) announced the acquisition of Mettrum (TSXV: MT) (OTC: MQTRF), Mettrum issued a press release providing an update regarding a pesticide-related recall:

With reference to Mettrum’s press release on November 1st, 2016, as a result of further testing and working with the full cooperation of Health Canada, Mettrum plans to voluntarily add a small number of additional product lots to the scope of its existing Type III voluntary withdrawal.

Today, The Globe & Mail has reported that the recall was related to myclobutanil, which is sold under brand names Eagle 20 and Nova 40 and has been at the center of attention in the United States cannabis industry this year due to its use despite its known dangers. Myclobutanil converts to hydrogen cyanide upon combustion. The use of the pesticide was the reason for the widespread recalls in Colorado that began in 2015.

Health Canada, which didn’t publicly disclose the issue, maintains a page for reporting compliance issues to the public, but it hasn’t been updated in more than six months. Mettrum informed The Globe and Mail that the recalled lots had only “trace levels” of the banned pesticide.

Read Grant Robertson’s “Canadians not told about banned pesticide found in medical pot supply”: http://www.theglobeandmail.com/news/national/canadians-not-told-about-banned-pesticide-found-in-medical-marijuana-supply/article33443887/

Get ahead of the crowd by signing up for 420 Investor, the largest & most comprehensive premium subscription service for cannabis traders and investors since 2013.

Published by NCV Newswire The NCV Newswire by New Cannabis Ventures aims to curate high quality content and information about leading cannabis companies to help our readers filter out the noise and to stay on top of the most important cannabis business news. The NCV Newswire is hand-curated by an editor and not automated in anyway. Have a confidential news tip? Get in touch